0

small cell lung cancer symptoms and signs

báo cáo hóa học:

báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx

Hóa học - Dầu khí

... J Cancer 2001, 94:153-156.2. Non -small Cell Lung Cancer Collaborative Group: Chemotherapyin non small cell lung cancer: a meta-analysis using updateddata on individual patients from 52 randomized ... Tonato M: Gemcitabine and cisplatin versus mito-mycin, ifosfamide, and cisplatin in advanced non -small- cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J Clin ... sur-vival and improve quality of life in non -small cell lung cancer: a review of the literature and future directions. Clin Cancer Res1998, 4:1087-1100.4. Le Chevalier T, Brisgand D, Douillard...
  • 8
  • 538
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot

Báo cáo khoa học

... stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999, 43:39-45.31. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors predicting radiation pneumonitis in lung cancer ... locally advanced non -small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapyAnhui Shi, Guangying Zhu*, Hao Wu, Rong Yu, Fuhai Li and Bo XuAbstractBackground: ... dosimetric factors and severe acute radiation pneumonitis (SARP) in patients with locally advanced non -small cell lung cancer (LANSCLC) treated with concurrent chemotherapy and intensity-modulated...
  • 8
  • 371
  • 0
Báo cáo hóa học:

Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf

Hóa học - Dầu khí

... mutations in lung cancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lung cancer (NSCLC) cell lines and tumor samples ... Non -small- cell lung cancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... analyses [10,11].MethodsSources of cell lines and cultureThe PC-9 lung tumor cell line was kindly provided byRoche (Basel, Switzerland); the A549 and H460 cell lineswere purchased from the...
  • 8
  • 798
  • 0
Báo cáo hóa học:

Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt

Hóa học - Dầu khí

... and for clinical-pathological reasons are often dividedinto two broad categories: small cell lung cancer (SCLC) and non -small cell lung cancer (NSCLC). All majorhistological types of lung cancer ... oesophagus, head and neck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate thehypothesis of HPV involvement in small cell lung cancer pathogenesis ... pathogenesis of lung cancer. Annu Rev Physiol 2002, 64:681-708.13. Syrianen KJ: HPV infections and lung cancer. J Clin Pathol 2002,55:885-891.14. zur Hausen H: Papillomaviruses and cancer: from...
  • 11
  • 471
  • 0
Báo cáo hóa học:

Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot

Hóa học - Dầu khí

... tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. Geneva, Switzerland: ... isoforms, PTEN and PI3K in tumorepithelial cells and stromal compartment in non -small cell lung cancer. Anticancer Res 2009, 29:4175-83.28. Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes ... histology. Lung Cancer 2010.31. Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM:Prognostic impact of platelet-derived growth factors in non -small cell lung cancer tumor and stromal...
  • 9
  • 662
  • 0
báo cáo hóa học:

báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot

Hóa học - Dầu khí

... Staging of small cell and non -small cell lung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... the most life-threatening form of cancer in Scot-land [2]. Lung cancer is also a major cause of deaththroughout the rest of the world [3,4].Non -small cell lung cancer (NSCLC) has a poor progno-sis. ... diseaseprogression and severe toxicities in NSCLC.BackgroundIn 2002, approximately 29,000 people died from lung cancer in England and Wales[1] and it is the most com-mon and the most life-threatening...
  • 15
  • 397
  • 0
Báo cáo toán học:

Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx

Báo cáo khoa học

... Lung cancer is one of the most common human cancers and the leading cause of cancer death world-wide (1). Lung cancer is generally classified into two histological types, small cell lung cancer ... gefitinib in non -small cell lung cancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- cell lung cancer patients ... factor receptor and non -small- cell lung cancer. J Med Genet. 2007; 44(3): 166-72. 41. Riely GJ, Pao W, Pham D, et al. Clinical course of patients with non -small cell lung cancer and epidermal...
  • 9
  • 203
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx

Báo cáo khoa học

... byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, ... treatment.IntroductionIn non -small cell lung cancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity. In fact, while 9% of patients with IIIA-N2NSCLC is candidate for surgery ... Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless,...
  • 4
  • 303
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx

Báo cáo khoa học

... non -small cell lung cancer. Lung Cancer 2003,41:1-11.17. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M: Variation in thehypoxic fraction among mouse tumors of different types, sizes, and sites. ... non -small- cell lung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non -small cell lung ... (SBRT) for lung t umorswasintroducedinthemid1990s[1],andithasbeenperformed in many institutions as a new treatmentmodality for stage I primary lung cancer and oligometa-static lung cancer. Promising...
  • 7
  • 297
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer" pdf

Báo cáo khoa học

... properties, and morphological characteristics ofpermanent human small cell lung cancer cell lines. J Cancer Res ClinOncol 1987, 113:31-40.16. NCCN guidelines for small- cell lung cancer. [http://www.nccn.org/professionals/physician_gls/f_guidelines.asp].17. ... limited-stage small- cell lung cancer. Int J Radiat Oncol BiolPhys 2003, 56:355-359.5. Roof KS, Fidias P, Lynch TJ, Choi NC: Radiation dose escalation in limited-stage small- cell lung cancer. Int ... in limited-stage small cell lung cancer: facts, questions, prospects. Radiother Oncol 2000, 55:1-9.2. Murray N, Turrisi AT: A review of first-line treatment for small- cell lung cancer. J Thorac...
  • 9
  • 465
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx

Báo cáo khoa học

... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small Cell Lung Cancer BackgroundNon -small cell lung cancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients ... limited stage IV non -small cell lung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul Okunieff2 and Michael T Milano1*AbstractBackground: Standard therapy ... Milano1*AbstractBackground: Standard therapy for metastatic non small cell lung cancer (NSCLC) includes palliative systemicchemotherapy and/ or radiotherapy. Recent studies of patients with limited...
  • 7
  • 368
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps

Báo cáo khoa học

... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ... and theDutch Lung Cancer Research Group. The primary studyobjectives are to compare local and regional control, qual-ity of life and treatment costs at 2 and 5 years in patientswho are randomized ... Therefore, an additional planning study wasperformed in 22 stage IA and 4 stage 1B non -small cell lung cancer patients in order to develop and evaluate theplanning guidelines differentiated according...
  • 14
  • 308
  • 0

Xem thêm